Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis.

Zahra FT, Sajib MS, Ichiyama Y, Akwii RG, Tullar PE, Cobos C, Minchew SA, Doçi CL, Zheng Y, Kubota Y, Gutkind JS, Mikelis CM.

Sci Rep. 2019 Aug 12;9(1):11666. doi: 10.1038/s41598-019-48053-z.

2.

In Vitro Wound Healing Assays to Investigate Epidermal Migration.

Main KA, Mikelis CM, Doçi CL.

Methods Mol Biol. 2019 May 24. doi: 10.1007/7651_2019_235. [Epub ahead of print]

PMID:
31123996
3.

Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.

Akwii RG, Sajib MS, Zahra FT, Mikelis CM.

Cells. 2019 May 17;8(5). pii: E471. doi: 10.3390/cells8050471. Review.

4.

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis.

Hossian AKMN, Muthumula CMR, Sajib MS, Tullar PE, Stelly AM, Briski KP, Mikelis CM, Matthaiolampakis G.

J Vis Exp. 2019 Mar 30;(145). doi: 10.3791/59460. Erratum in: J Vis Exp. 2019 Apr 26;(146):.

PMID:
30985742
5.

Matrigel Plug Assay for In Vivo Evaluation of Angiogenesis.

Kastana P, Zahra FT, Ntenekou D, Katraki-Pavlou S, Beis D, Lionakis MS, Mikelis CM, Papadimitriou E.

Methods Mol Biol. 2019;1952:219-232. doi: 10.1007/978-1-4939-9133-4_18.

PMID:
30825178
6.

In Vitro Spheroid Sprouting Assay of Angiogenesis.

Zahra FT, Choleva E, Sajib MS, Papadimitriou E, Mikelis CM.

Methods Mol Biol. 2019;1952:211-218. doi: 10.1007/978-1-4939-9133-4_17.

PMID:
30825177
7.

DNA Repair Response Adaptors: Novel Targets for Vasoproliferative Retinopathy?

Sajib MS, Mikelis CM.

Thromb Haemost. 2019 Mar;119(3):358. doi: 10.1055/s-0038-1677022. Epub 2019 Jan 8.

PMID:
30620993
8.

Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.

Ashraf-Uz-Zaman M, Sajib MS, Cucullo L, Mikelis CM, German NA.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3652-3657. doi: 10.1016/j.bmcl.2018.10.036. Epub 2018 Oct 24.

PMID:
30389290
9.

Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.

Hossian AKMN, Sajib MS, Tullar PE, Mikelis CM, Mattheolabakis G.

Sci Rep. 2018 Jul 12;8(1):10495. doi: 10.1038/s41598-018-28872-2.

10.

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models.

Punganuru SR, Madala HR, Mikelis CM, Dixit A, Arutla V, Srivenugopal KS.

Oncotarget. 2018 May 25;9(40):26109-26129. doi: 10.18632/oncotarget.25450. eCollection 2018 May 25.

11.

GM-CSF therapy in human caspase recruitment domain-containing protein 9 deficiency.

Drummond RA, Zahra FT, Natarajan M, Swamydas M, Hsu AP, Wheat LJ, Gavino C, Vinh DC, Holland SM, Mikelis CM, Lionakis MS.

J Allergy Clin Immunol. 2018 Oct;142(4):1334-1338.e5. doi: 10.1016/j.jaci.2018.05.025. Epub 2018 Jun 8. No abstract available.

PMID:
29890237
12.

The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

Collar AL, Swamydas M, O'Hayre M, Sajib MS, Hoffman KW, Singh SP, Mourad A, Johnson MD, Ferre EM, Farber JM, Lim JK, Mikelis CM, Gutkind JS, Lionakis MS.

JCI Insight. 2018 Feb 8;3(3). pii: 95417. doi: 10.1172/jci.insight.95417. eCollection 2018 Feb 8.

13.

Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions.

Sajib S, Zahra FT, Lionakis MS, German NA, Mikelis CM.

Angiogenesis. 2018 Feb;21(1):1-14. doi: 10.1007/s10456-017-9583-4. Epub 2017 Nov 6. Review.

PMID:
29110215
14.

Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes.

Doçi CL, Mikelis CM, Callejas-Valera JL, Hansen KK, Molinolo AA, Inoue A, Offermanns S, Gutkind JS.

PLoS One. 2017 Mar 16;12(3):e0173692. doi: 10.1371/journal.pone.0173692. eCollection 2017.

15.

Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.

Rieber N, Gazendam RP, Freeman AF, Hsu AP, Collar AL, Sugui JA, Drummond RA, Rongkavilit C, Hoffman K, Henderson C, Clark L, Mezger M, Swamydas M, Engeholm M, Schüle R, Neumayer B, Ebel F, Mikelis CM, Pittaluga S, Prasad VK, Singh A, Milner JD, Williams KW, Lim JK, Kwon-Chung KJ, Holland SM, Hartl D, Kuijpers TW, Lionakis MS.

JCI Insight. 2016 Oct 20;1(17):e89890. doi: 10.1172/jci.insight.89890.

16.

CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System.

Drummond RA, Collar AL, Swamydas M, Rodriguez CA, Lim JK, Mendez LM, Fink DL, Hsu AP, Zhai B, Karauzum H, Mikelis CM, Rose SR, Ferre EM, Yockey L, Lemberg K, Kuehn HS, Rosenzweig SD, Lin X, Chittiboina P, Datta SK, Belhorn TH, Weimer ET, Hernandez ML, Hohl TM, Kuhns DB, Lionakis MS.

PLoS Pathog. 2015 Dec 17;11(12):e1005293. doi: 10.1371/journal.ppat.1005293. eCollection 2015 Dec.

17.

Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.

O'Hayre M, Inoue A, Kufareva I, Wang Z, Mikelis CM, Drummond RA, Avino S, Finkel K, Kalim KW, DiPasquale G, Guo F, Aoki J, Zheng Y, Lionakis MS, Molinolo AA, Gutkind JS.

Oncogene. 2016 Jul 21;35(29):3771-80. doi: 10.1038/onc.2015.442. Epub 2015 Nov 30.

18.

Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma.

Doçi CL, Mikelis CM, Lionakis MS, Molinolo AA, Gutkind JS.

Cancer Res. 2015 Jul 15;75(14):2937-48. doi: 10.1158/0008-5472.CAN-14-3121. Epub 2015 May 7.

19.

RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock.

Mikelis CM, Simaan M, Ando K, Fukuhara S, Sakurai A, Amornphimoltham P, Masedunskas A, Weigert R, Chavakis T, Adams RH, Offermanns S, Mochizuki N, Zheng Y, Gutkind JS.

Nat Commun. 2015 Apr 10;6:6725. doi: 10.1038/ncomms7725.

20.

SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.

Dillenburg-Pilla P, Patel V, Mikelis CM, Zárate-Bladés CR, Doçi CL, Amornphimoltham P, Wang Z, Martin D, Leelahavanichkul K, Dorsam RT, Masedunskas A, Weigert R, Molinolo AA, Gutkind JS.

FASEB J. 2015 Mar;29(3):1056-68. doi: 10.1096/fj.14-260083. Epub 2014 Dec 2.

21.

Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes oral cancer metastasis.

Gan CP, Patel V, Mikelis CM, Zain RB, Molinolo AA, Abraham MT, Teo SH, Abdul Rahman ZA, Gutkind JS, Cheong SC.

Oncotarget. 2014 Oct 30;5(20):9626-40.

22.
23.

PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation.

Mikelis CM, Palmby TR, Simaan M, Li W, Szabo R, Lyons R, Martin D, Yagi H, Fukuhara S, Chikumi H, Galisteo R, Mukouyama YS, Bugge TH, Gutkind JS.

J Biol Chem. 2013 Apr 26;288(17):12232-43. doi: 10.1074/jbc.M112.428599. Epub 2013 Mar 6.

24.

CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis.

Pan W, Pham VN, Stratman AN, Castranova D, Kamei M, Kidd KR, Lo BD, Shaw KM, Torres-Vazquez J, Mikelis CM, Gutkind JS, Davis GE, Weinstein BM.

Blood. 2012 Jul 12;120(2):489-98. doi: 10.1182/blood-2012-02-408328. Epub 2012 May 30.

25.

Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.

Patel V, Marsh CA, Dorsam RT, Mikelis CM, Masedunskas A, Amornphimoltham P, Nathan CA, Singh B, Weigert R, Molinolo AA, Gutkind JS.

Cancer Res. 2011 Nov 15;71(22):7103-12. doi: 10.1158/0008-5472.CAN-10-3192. Epub 2011 Oct 5. Erratum in: Cancer Res. 2012 Feb 1;72(3):826. Nathan, Cherie Ann [corrected to Nathan, Cherie-Ann O].

Supplemental Content

Loading ...
Support Center